BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15363320)

  • 21. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel method for simultaneous analysis of p53 and K-ras mutations and p53 protein expression in single histologic sections.
    Yamashita K; Yoshida T; Shinoda H; Okayasu I
    Arch Pathol Lab Med; 2001 Mar; 125(3):347-52. PubMed ID: 11231481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer.
    Nayak BK; Baral RN; Das BR
    Neoplasma; 1996; 43(5):305-10. PubMed ID: 8996549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent expression of p53 protein without mutation in the atypical epithelium of human bronchus.
    Wakamatsu K; Nakanishi Y; Takayama K; Miyazaki H; Hayashi K; Hara N
    Am J Respir Cell Mol Biol; 1999 Aug; 21(2):209-15. PubMed ID: 10423403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
    Dahiya R; Deng G; Selph C; Carroll P; Presti J
    Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.
    Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL
    Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathological analysis of mucinous adenocarcinomas of the stomach.
    Wu M; Semba S; Li D; Yokozaki H
    Pathobiology; 2004; 71(4):201-10. PubMed ID: 15263809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The expression of mutant p53 gene in gastric carcinoma].
    Liu J; Hu JL; Zhu MH
    Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):370-2. PubMed ID: 7867423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of p53 mutations with metastatic prostate cancer.
    Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
    Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.
    Jeffers MD; Farquharson MA; Richmond JA; McNicol AM
    J Pathol; 1995 Sep; 177(1):65-70. PubMed ID: 7472782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
    Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
    Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of loss of heterozygosity of p53 gene in paraffin-embedded breast cancers by non-isotopic PCR-SSCP.
    Chen YH; Li CD; Yap EP; McGee JO
    J Pathol; 1995 Oct; 177(2):129-34. PubMed ID: 7490678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas.
    Bazan V; La Rocca G; Corsale S; Agnese V; Macaluso M; Migliavacca M; Gregorio V; Cascio S; Sisto PS; Di Fede G; Buscemi M; Fiorentino E; Passantino R; Morello V; Tomasino RM; Russo A
    J Cell Physiol; 2005 Feb; 202(2):503-9. PubMed ID: 15316933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 gene mutations in gastric carcinoma detected by polymerase chain reaction/single-strand conformation polymorphism analysis of archival material.
    D'Andrea E; Baffa R; Menin C; Montagna M; Rugge M; Chieco-Bianchi L
    J Cancer Res Clin Oncol; 1995; 121(2):79-83. PubMed ID: 7883779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma.
    Anzola M; Saiz A; Cuevas N; Lopez-Martinez M; Martinez de Pancorbo MA; Burgos JJ
    J Viral Hepat; 2004 Nov; 11(6):502-10. PubMed ID: 15500550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression and mutation of p53 and H-ras genes in the carcinogenesis and development of gastric adenocarcinoma induced by MNNG in rats].
    Meng Z; Lei D; Wang J
    Zhonghua Bing Li Xue Za Zhi; 1998 Apr; 27(2):117-9. PubMed ID: 11244961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer.
    Pan ZZ; Wan DS; Chen G; Li LR; Lu ZH; Huang BJ
    World J Gastroenterol; 2004 Dec; 10(24):3688-90. PubMed ID: 15534934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphologic, histologic, and molecular similarities between adenocarcinomas arising in the gastric stump and the intact stomach.
    Safatle-Ribeiro AV; Ribeiro Júnior U; Reynolds JC; Gama-Rodrigues JJ; Iriya K; Kim R; Bakker A; Swalsky PA; Pinotti HW; Finkelstein SD
    Cancer; 1996 Dec; 78(11):2288-99. PubMed ID: 8940997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.